Bendamustine and Bortezomib Combination Therapy in Indolent Non-Hodgkin's Lymphoma(NHL)

Clinical trial NCT00426855 · COMPLETED

Trial details

NCT number: NCT00426855
Sponsor: Peter Moosmann
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin

Start date: 2007-01-01
Primary completion: 2009-02-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.